Cargando…
Newborn Screening: Review of its Impact for Cystinosis
Newborn screening (NBS) programmes are considered to be one of the most successful secondary prevention measures in childhood to prevent or reduce morbidity and/or mortality via early disease identification and subsequent initiation of therapy. However, while many rare diseases can now be detected a...
Autores principales: | Hohenfellner, Katharina, Elenberg, Ewa, Ariceta, Gema, Nesterova, Galina, Soliman, Neveen A., Topaloglu, Rezan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997957/ https://www.ncbi.nlm.nih.gov/pubmed/35406673 http://dx.doi.org/10.3390/cells11071109 |
Ejemplares similares
-
Management of bone disease in cystinosis: Statement from an international conference
por: Hohenfellner, Katharina, et al.
Publicado: (2019) -
Molecular based newborn screening in Germany: Follow-up for cystinosis
por: Hohenfellner, Katharina, et al.
Publicado: (2019) -
Expert guidance on the multidisciplinary management of cystinosis in adolescent and adult patients
por: Levtchenko, Elena, et al.
Publicado: (2022) -
Cystinosis: the evolution of a treatable disease
por: Nesterova, Galina, et al.
Publicado: (2012) -
Effects of long-term cysteamine treatment in patients with cystinosis
por: Ariceta, Gema, et al.
Publicado: (2017)